Trade Tariffs on Canadian Pharmaceuticals—Implications for US Drug Supply and Costs
This cross-sectional study analyzes data from the National Institutes of Health, IQVIA, and the US Food and Drug Administration on pharmaceutical drugs manufactured in Canada and exported to the US.
Authors
- Ioannis Konstantinidis (ORCID: https://orcid.org/0000-0001-6785-1318)
- Katie J. Suda
- Mina Tadrous (ORCID: https://orcid.org/0000-0003-1911-6129)
- Shanzeh Chaudhry (ORCID: https://orcid.org/0009-0006-7838-8836)
- Jan Panhuysen (ORCID: https://orcid.org/0009-0006-5564-354X)
Institutions
- University of Pittsburgh (US)
- University of Toronto (CA)
- Hertie School (DE)
Publication Details
- Journal
- JAMA
- Published
- 2025-03-31
- DOI
- https://doi.org/10.1001/jama.2025.4583
- Citations
- 2
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 6.26